Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The r ...

Berkshire Hathaway (Class A) remains the most expensive stock globally at $730,000 per share in 2025. Lindt & Sprüngli AG, ...

Nature’s fury is on the rise! 🌪️ As tornadoes become more frequent, experts are linking this trend to changing climate ...

Mr. Trirat Suwanprateeb, Chief Executive Officer of SCB TechX, stated: "In today's data-driven era, fast and accurate access ...

Báo điện tử VOV, tin tức thời sự về chính trị, kinh tế, đời sống, xã hội, pháp luật, thể thao, văn hóa, giải trí, thế giới, nghe radio và xem TV của VOV ...

LONDON, GREATER LONDON, UNITED KINGDOM, June 5, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...

AstraZeneca (LSE:AZN) recently announced promising clinical trial results for ENHERTU, which may reflect its ongoing commitment to enhancing therapeutic options for HER2-positive metastatic breast ...

AstraZeneca has declined to announce a price for camizestrant if it receives government approval. But a similar drug, elacestrant, made by Stemline Therapeutics, typically costs $26,467.56 a month.

AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ongoing $3.5 billion investment in American innovation.

AstraZeneca moves some production to US amid tariff threat. London (AFP) – British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to ...

AstraZeneca saw 18% revenue growth in 2024, boosted by key drugs and global innovation. ... Additionally, I have been involved in managing cross-border M&A transactions in Indonesia, ...

AstraZeneca signs deals with Harbour BioMed and Syneron Bio for platform technologies The drugmaker collaborated with Chinese biotech Harbour BioMed to gain an option to license multiple programs ...